Is Mangoceuticals, Inc. (MGRX) a Buy, Sell, or Hold?
NASDAQ : MGRX
Mangoceuticals, Inc.
$0.5571 USD
$0.26 (89.75%)
- Volume
- 506.74M
- Average Volume
- 10.59M
- Market Capitalization
- $5.65M
- P/E Ratio
- -0.32
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.75
- Year Low
- $0.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.03
- Current Ratio
- $0.29
Company Overview
NASDAQ
Jacob D. Cohen
Medical - Healthcare Information Services
Healthcare
MGRX
3
US
USD
Liquidity Metrics
0.02
0.29
0.29
0.24
-0.03
Sales & Valuation
$456.02K
13.62
0.42
-1.16
-0.49
Profitability
-$2.05
-$20.64M
-4632.94%
-4632.92%
-120.71%
-132.93%
P/E Metrics
-0.32
0.00
0.00
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-6.81
2/9
-$525.13K
$14.45M
$974.57K
-$19.09M
Key Metrics (TTM)
$5.77M
13.91
-0.33
0.29
-120.71%
-126.58%
-342.32%
-86.56%
-963 days
Company Executives
| Name | Title |
|---|---|
| Eugene Johnston | Chief Financial Officer |
| Jacob D. Cohen | Co-Founder, Chief Executive Officer & Chairman |
Poll Results
No votes yet today — be the first to share your view!
About Mangoceuticals, Inc. (NASDAQ:MGRX) Stock
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc. ...
2026-07-30 10:35:00
Transaction positions Nuclea to fund the development and commercialization of its lead-cooled, factory-built microreactor as AI and data center growth drives a generational expansion in U.S. electricity demand Mississauga, Ontario--(Newsfile Corp. - July 30, 2026) - Nuclea Energy Inc. ("Nuclea" or the "Company"), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing the Morpheus microreactor, a lead-cooled, factory-built micro-modular reactor, today announced that it has entered into a definitive business combination agreement (the "Business Combination Agreement") with Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals"). "This agreement gives Nuclea a faster path to the public markets at a defining moment for our industry.
2026-07-30 07:00:00
Business Combination Agreement to Bring Nuclea's Lead-Cooled Morpheus Microreactor to the Public Markets Amid Surging Power Demand from AI and Data Centers DALLAS, TEXAS, July 30, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) today announced that it has entered into a definitive business combination agreement (the “Agreement”) with Nuclea Energy Inc. (“Nuclea”), an advanced nuclear technology company founded in August 2023 and headquartered in Mississauga, Ontario, developing the Morpheus microreactor, a lead-cooled, factory-built micro-modular reactor. Nuclea is advancing its Morpheus nuclear reactor from the current design stage through an 18-month development roadmap toward regulatory and commercial readiness.
Frequently Asked Questions
-
What is the current Mangoceuticals, Inc. (MGRX) stock price?
-
Mangoceuticals, Inc.(NASDAQ:MGRX) stock price is $0.5571 in the last trading session. During the trading session, MGRX stock reached the peak price of $2.75 while $0.162 was the lowest point it dropped to. The percentage change in MGRX stock occurred in the recent session was 89.75% while the dollar amount for the price change in MGRX stock was $0.26.
-
MGRX's industry and sector of operation?
-
The NASDAQ listed MGRX is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of MGRX?
-
Eugene Johnston | Chief Financial Officer
Jacob D. Cohen | Co-Founder, Chief Executive Officer & Chairman
|
|
| -
How many employees does MGRX have?
-
Number of MGRX employees currently stands at 3. MGRX operates from 15110 North Dallas Parkway, Dallas, TX 75248, US.
-
Link for MGRX official website?
-
Official Website of MGRX is: https://www.mangoceuticals.com
-
How do I contact MGRX?
-
MGRX could be contacted at phone #(214) 242-9619 and can also be accessed through its website. MGRX operates from 15110 North Dallas Parkway, Dallas, TX 75248, US.
-
How many shares of MGRX are traded daily?
-
The average number of MGRX shares traded daily for last 3 months was 10.59M.
-
What is the market cap of MGRX currently?
-
The market value of MGRX currently stands at $5.65M with its latest stock price at $0.5571